ArticleFrontiers in oncology2022

Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh Class A Liver function: A Pilot Study.

Feiqian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.